Related Experiment Video

Updated: May 10, 2026

Development and Application of Rapamycin-regulated Tyrosine Phosphatases
06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Mechanistic target of rapamycin controls homeostasis of adipogenesis

Mee-Sup Yoon1, Chongben Zhang1, Yuting Sun1

  • 1Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801.

Journal of Lipid Research
|June 7, 2013
PubMed

Insights

Mechanistic target of rapamycin (mTOR) signaling unexpectedly suppresses adipogenesis. Reducing mTOR levels in preadipocytes enhances differentiation by increasing key adipogenic factors.

Area of Science:

  • Cell Biology
  • Metabolic Signaling
  • Adipogenesis Research

Background:

  • Mechanistic target of rapamycin (mTOR) signaling is widely considered crucial for adipogenesis.
  • Previous studies relied on indirect evidence, lacking direct genetic proof for mTOR's role in preadipocyte differentiation.

Purpose of the Study:

  • To investigate the direct, autonomous role of mTOR in preadipocyte differentiation using a conditional knockdown approach.
  • To elucidate the molecular mechanisms underlying mTOR's influence on adipogenesis.

Main Methods:

  • Conditional knockdown of mTOR in 3T3-L1 preadipocytes.
  • Assessment of preadipocyte differentiation markers.
  • Analysis of key adipogenic transcription factors, including C/EBPα and PPARγ.
  • Investigation of signaling pathways involving Akt, mTORC1, and IRS1.

Main Results:

  • Knockdown of S6K1, an mTOR target, impaired differentiation, contrasting with mTOR reduction.
  • Reduced mTOR levels unexpectedly enhanced 3T3-L1 preadipocyte differentiation.
  • Enhanced adipogenesis in mTOR-depleted cells required residual mTOR activity.
  • mTOR knockdown increased levels of C/EBPα and PPARγ.
  • Partial mTOR reduction modulated the IRS1-Akt pathway, leading to increased adipogenesis.

Conclusions:

  • mTOR plays a previously unrecognized suppressive role in adipogenesis.
  • mTOR regulates adipogenic homeostasis through intricate modulation of multiple signaling pathways, including the IRS1-Akt axis.
  • These findings challenge existing paradigms and offer new insights into metabolic regulation.
Keywords:
CCAAT/enhancer-binding protein αadipocytesmechanistic target of rapamycin complex 1peroxisome proliferator-activated receptor γ

More Related Videos

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...